🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Synthetic GLP-1 lowers postprandial (pp) glycemia by stimulating insulin, i...
Status
Completed
Location
Department of Internal Medicine II, University of Munich
Start Date
2004-10
Trial ID
NCT00980083
Treatments Being Tested
Individuals with obesity have an increased risk for heart disease and diabe...
Status
Unknown
Location
Veteran's Affairs Clinical Research Unit
Start Date
2013-02
Trial ID
NCT01760772
The purpose of the study is to determine the contribution of endogenous Glu...
Status
Completed
Location
Ludwig Maximilians-University, Clinical Research Unit
Start Date
2006-12
Trial ID
NCT01449019
Treatments Being Tested
The purpose of this study is to determine the dose of the GLP-1 receptor an...
Status
Completed
Location
Ludwig Maximilians University, Clinical Research Unit
Start Date
2006-11
Trial ID
NCT00393445
Type 1 diabetes is a serious and burdensome disease that carries the risk o...
Status
Completed
Location
Gentofte Hospital
Start Date
2026-01-23
Trial ID
NCT07373236
Treatments Being Tested
The purpose of this study in humans is to define the effects of the endogen...
Status
Completed
Location
Clinical Research unit, Dept. of Internal Medicine II - Großhadern, University of Munich
Start Date
1999-02
Trial ID
NCT00468091
Treatments Being Tested